Advances in Food Technology and Nutritional Sciences

Open journal

ISSN 2377-8350

Crosstalk between Autophagy and Obesity: Potential Use of Avian Model

Irina Angel

Sami Dridi, PhD

Associate Professor Center of Excellence for Poultry Science, University of Arkansas 1260 W. Maple Street Fayetteville, AR 72701, USA;
Tel. (479)-575-2583; Fax: (479)-575-7139; E-mail: dridi@uark.edu

INTRODUCTION

Autophagy is a highly conserved cellular mechanism that is responsible for the degradation and recycling of damaged organelles. In recent years though, autophagy has appeared to play critical roles in several cellular functions and physiological processes. Although originally described in 1960 by Christian de Duve, the founding father of autophagy,1 first autophagyrelated proteins were only recently identified (in 2008) which makes autophagy a relatively new and thriving field of study. Autophagy was used to distinguish the ‘eating’ (phagy) of part of the cell’s self (auto) from the breakdown of extracellular material (heterophagy).2 The name was coined from the observation of electron microscopy studies that showed novel single or double-membrane vesicles containing organelles in various stages of degradation1,3 and, therefore, distinguishes it from the ubiquitine (Ub)-proteosome pathway that is specific for the degradation of short-lived proteins.

There are three major types of autophagy; micro-, macro-autophagy, and chaperonemediated autophagy.4,5 Micro- and macro-autophagy can selectively engulf large structures such as mitochondria and endoplasmic reticulum (referred to as mitophagy or reticulophagy, respectively6,7) or by non-selective mechanisms (e.g. bulk cytoplasm), whereas chaperonemediated autophagy degrades only soluble proteins.8 Micro-autophagy refers to the sequestration of cytosolic components directly by lysosomes through invaginations in their limiting membrane. However, macro-autophagy that we will address in the present review refers to the sequestration of material within an autophagosome, a unique double membrane cytosolic vesicle. Autophagosomes fuse with late endosomes and lysosomes, promoting the delivery of organelles, aggregated proteins and cytoplasm to the luminal acidic degradative milieu that enables their breakdown into constituent molecular building blocks that can be recycled by the cell.9

Although autophagy was first observed in mammalian cells, the molecular mechanisms were delineated in yeast. A number of protein complexes and signaling pathways that regulate autophagy have been identified in yeast and many of these have mammalian orthologs. A breakthrough for studying the molecular basis of this pathway was through identifying the Atg (Autophagy-related) genes.10 There are currently more than 30 Atg genes that have been identified in yeast as well as functionally characterized orthologs of the Atg gene products in higher eukaryotes including: mammals, insects, worms, and plants.11,12

Knowledge gained over the past decade about the mechanisms that underpin autophagy has provided a universal framework for studies of diverse (patho)-physiological processes. Of particular interest is the emerging role of autophagy in the regulation of energy homeostasis.13 Dysregulation of autophagy might contribute to the development of metabolic disorders such as obesity and insulin resistance. Using different experimental animal models may shed light on these underlying molecular mechanisms and may help to develop new therapeutic strategies. In the following sections we will briefly describe the autophagosome formation from initiation to maturation, their interaction with nutrition in the development of metabolic syndrome and unique metabolic characteristics of avian species that argue for birds becoming a model of choice to study the molecular mechanisms involved in obesity.

Autophagosome Process

The autophagy process contains genes that function in key stages of the pathway: initiation (or induction), elongation, maturation, and fusion with the lysosomes are shown in figure 1. First, Atgs are concentrated on single lipid bilayer membranes called phagophores that bud from pre-existing mitochondria or ER and modulate membrane elongation to form cup-shaped structures that engulf cytoplasmic components to generate spherical autophagosomes.14

Figure 1: Steps of autophagosome formation: Autophagosome formation can be initiated via mTOR inhibition or AMPK activation during starvation or nutrient limitation.

AFTNSOJ-1-106Fig1

This results in the activation of ULK1 which in turn phosphorylates Atg13, Atg101 and FIP200. When autophagy is activated, Beclin 1 is liberated from Bcl-2 and is associated with Vps34, Vps15 and Atg14. ULK1 phosphorylates also AMBRA, a component of the PI3K CIII complex enabling it to relocate from the cytoskeleton to the isolation membrane. The activation of Vps34 generates PI3P which catalyzes the first of two types of ubiquitination-like reactions that regulates membrane elongation. Firstly, Atg5 and Atg12 are conjugated to each other in the presence of Atg7 and Atg10. Attachment of the Atg5-Atg12-Atg16L1 complex on the isolation membrane induces the second complex to covalently conjugate PE to LC3 which facilitates in turn the closure of the isolation membrane. The complex Atg9-Atg2-atg18 cycles between endosomes, the Golgi and the phagophore possibly carrying lipid components for membrane expansion. LC3-II is formed by LC3 conjugation to its lipid target PE and Atg4 removes LC3-II from the outer surface of newly formed autophagosome, and LC3 on the inner surface is degraded when the autophagosome fuses with lysosomes. AMBRA, autophagy/beclin-1 regulator 1; Atg, autophagyrelated genes; LC3, microtubule-associated protein light chain; PE, phosphatidylethanolamine; PI3K, phosphatidylinositol 3 kinase; PIP3, phosphatidylinositol 3-phosphate; ULK1, UNC51-like kinase1.

 

The autophagosome-lysosome fusion releases the autophagosome content into the lysosome lumen for degradation. Under fed (normal nutrient-energy adequate) state, the nutrient sensor mechanistic target of rapamycin (mTOR) is activated and in turn phosphorylates ULK1 and thereby sequestering the ULK1-Atg13-FIP200 complex in an inactive state at the mTOR complex.15 In contrast when nutrients are limited (e.g. during stress or starvation), the energy sensor AMPK is activated. AMPK activation inhibits mTOR activity leading to a reduced ULK1 phosphorylation and consequently releases the ULK1- Atg13-FIP200 complex from mTOR to the site of autophagosome formation and induction of autophagy. In the second step of autophagy, Beclin1 forms a lipid kinase complex with vacuolar sorting proteins Vps15, Vps34 and Atg14 that phosphorylates phosphatidylinositol (PI) to form inositol-3-phosphate (PI3P) and is essential for induction of autophagy14. Accumulation of PI3P in specific sub-domains of the ER increases membrane curvature at the site of autophagosome formation. The elongation step involves two ubiquitin-like reactions of the pre-autophagosomal structures. First, the ubiquitin-like protein Atg12 is conjugated to Atg5 by the action of Atg7 and Atg10 after which Atg16 multimerizes to form the Atg12-Atg5-Atg16 complex. Next, Atg4 cleaves soluble microtubule-associated protein light chain 3-I (LC3-I) to form the membrane-bound LC3-II. Both of these two ubiquitin-like systems are required for elongation and closure of the phagophore. During maturation and fusion, autophagosomes will first fuse with endosomes then with lysosomes. Any mutation or loss of proteins important for formation of multivesicular bodies (MVBs) can lead to inhibition of maturation of autophagosomes.16,17 Some genes involved in this step include UVRAG, a Beclin 1 interacting protein that recruits the fusion machinery on the autophagosomes. Another Beclin 1 interacting protein, Rubicon, also functions in the maturation of autophagosomes where it is thought to be a part of a distinct Beclin 1 complex containing Vps34, Vps15, and UVRAG that suppresses autophagosome maturation.18,19 Working together, these steps complete the formation of the autolysosome and its lysis, that releases proteins and amino acids that can be used as an energy source during times of low energy availability or increased energy demand (stress) for the organism (Figure 1).

Autophagy and Development of Obesity

Obesity is a devastating multifactorial disease that continues to rise and has become an epidemic in the world with rates in the U.S. being among the highest.20 Fat accumulation and fat cell hypertrophy in human are strongly associated with autophagy, and autophagy elevation is particularly prominent in the omental fat of individuals who developed obesity-related insulin resistance.21 Using the chicken and egg analogy, it is not known which came first; obesity or adipose autophagy.

Current evidence implicates autophagy in the regulation of lipid stores within the two main organs involved in maintaining lipid homeostasis, namely the liver and adipose tissue.22 In the hepatocytes, cytoplasmic lipid droplets were found to be subject to breakdown by autophagy, a process referred to as lipophagy. Pharmacological or genetic inhibition of Atg5 increased triglyceride levels and decreased β-oxidation in a rat hepatocyte cell line.23 Moreover, hepatic lipid droplets were found to be colocalized with LC3 under basal and autophagy-induced conditions. Specific inhibition of hepatic Atg7 caused an accumulation of lipid within the mouse liver23 indicating that autophagy regulate hepatic lipid turnover.

In adipocytes, however, autophagy appears to have an opposite effect on lipid stores. Indeed, autophagy is required for adipocyte differentiation and lipid droplet accumulation.24,25 Atg7 adipocyte-specific knockout reduced white adipose tissue and increased brown adipose tissue along with increased rate of β-oxidation. Recent studies showed also that autophagy regulates lipid metabolism through lipoprotein assembly and apoB degradation.26,27 ApoB was found to be co-localized with autophagosomes in docosahexaenoic acid-treated McA cells, and knockout of Atg7 gene increased apoB recovery.28

It is well known that a high fat diet and increased obesity induces insulin resistance in liver, adipose tissue and muscle resulting in hyperglycemia.29 It has been shown that an excess in nutrient supply down-regulated autophagy via insulin signaling.30 Recent studies found that hepatic autophagy is defective and its up-regulation improves insulin sensitivity in common rodent obese models (ob/ob, db/db and HFD).31,32,33 Furthermore, insulin inhibited autophagy via mTOR activation and mTOR inhibition by rapamycin lead to a hyperinsulinemic and hyperglycaemic states in rat skeletal muscle.34,35 These results indicate that insulin and autophagy might participate in a feedback mechanism of reciprocal regulation. Thus, autophagy may regulate insulin sensitivity in a tissue specific manner. For instance, HFD decreased and increased LC3-II levels in mouse liver and adipose tissue, respectively.21

Autophagy and Avian Species: A Model of Choice

As the incidence of obesity or metabolic syndrome continues to rise, there is a clear demand to identify new and efficient therapeutic strategies. Therefore, insights into the molecular mechanisms of this devastating disease using different experimental models are of uppermost interest. Rodents are very useful models for the study of obesity, but it could be suggested that another equally good model for this study would be chickens (Gallus gallus).

Whereas lipogenesis occurs in both adipose tissue and liver in rodents,36,37,38 chickens are similar to humans in that lipogenesis occurs exclusively in the liver and is exported via the circulatory system to adipose tissue.39 In addition, chickens are characteristically hyperglycemic compared with mammals, with their blood glucose levels averaging three times that found in humans (300 vs. 100 mg/dl).40 Genetic selection for production efficiency (rapid growth rate and feed efficiency) necessitates feed restriction in commercial meat-type chicken (broiler) breeders that are hyperphagic, heavy, and prone to obesity. Broilers voraciously consume approximately 4.1 kg of feed to achieve a 40-fold increase in body weight after hatch that is concomitant with tremendous increase in muscle development as well as abdominal fat during a period of 42 days.41,42 Both meat and egg producing chickens (broilers and layers) are insulin resistant43,44 and lack the glucose transporter protein GLUT4.45 They require insulin doses greater than four times that required in mammals to achieve hypoglycaemia.46

Obesity is often considered to be a result of either excessive food intake or insufficient energy expenditure. Brown Adipose Tissue (BAT), a specialized fat that dissipates energy to produce heat, plays an important role in the regulation of energy balance. Interestingly, chickens do not have functional BAT. Thus, these unique metabolic characteristics make chickens an interesting model for understanding the role of autophagy in obesity development.

Recently, we characterized several genes involved in autophagosome initiation, elongation and maturation in chickens (Gallus gallus) and Japanese quail (Coturnix coturnix japonica).47 These genes are ubiquitously expressed and showed high similarity with their mammalian orthologs indicating that autophagy is a conserved mechanism in different species. Interestingly, we found that the expression of autophagy-related genes is tissueand gender-dependent.47 For instance, it was found that hypothalamic Beclin1, UVRAC, Atg9a, Atg13, Atg4b, Atg7 and Atg5 mRNA levels were significantly higher in female compared to male chickens suggesting that hypothalamic autophagy might be involved in the regulation of feed intake. Recently, Kaushik and colleagues showed that autophagy regulates lipid metabolism within hypothalamic neurons which in turn modulate neuropeptide levels that control feed intake and energy homeostasis.48 Furthermore, using two experimental male quail lines divergently selected over 40 generations for low (resistant line) or high (sensitive line) stress response49 it was found that the expression of several autophagy-related genes are higher in several tissues including adipose tissue in the resistant compared to the sensitive line.47 Since autophagy has been shown to play a key role in stress response and fat metabolism and since the regulation of energy homeostasis and the stress response are coupled physiological processes, the differential expression of autophagy-related genes between the two quail lines indicated that these lines would be a very useful model to study the interaction between stress response, autophagy and fat metabolism.

In conclusion, studies using avian models may provide critical information on the role of autophagy in lipogenesis and lipid metabolism because the liver is the primary site of de novo fatty acid synthesis in chickens and may help for targeting new therapeutic strategies to treat obesity and its related diseases.

1. De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev. Physiol. 1966; 28: 435-492. doi: 10.1146/annurev.ph.28.030166.002251

2. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007; 8(11): 931-937.
doi: 10.1038/nrm2245

3. Clark SL, Jr. Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J Biophys Biochem Cytol. 1957; 3: 349-362. doi: 10.1083/jcb.3.3.349

4. Klionsky DJ. The molecular machinery of autophagy: Unanswered questions. J. Cell Sci. 2005; 118: 7-18. doi: 10.1242/jcs.01620

5. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol. 2006; 73: 205-235.
doi: 10.1016/S0070-2153(05)73007-6

6. Hasson SA, Kane LA, Yamano K, et al. High-content genome wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature. 2013; 504: 291-295. doi: 10.1038/nature12748

7. Tasdemir E, Maiuri MC, Tajeddine N, et al. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle. 2007; 6(18): 2263-2267. doi: 10.4161/cc.6.18.4681

8. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451: 1069-1075.
doi: 10.1038/nature06639

9. Hamasaki M, Furuta N, Matsuda A, et al. Autophagosomes form at ER-mitochondria contact sites. Nature. 2013; 495(7441):389-393.
doi: 10.1038/nature11910

10. Yorimitsu T, Klionsky DJ. Autophagy: Molecular machinery for self-eating. Cell Death Differ. 2005; 12: 1542-1552.
doi: 10.1038/sj.cdd.4401765

11. Reggiori F, Klionsky DJ. Autophagy in the eukaryotic cell. Eukaryot Cell. 2002; 1(1): 11-21. doi: 10.1128/EC.01.1.11-21.2002

12. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev. Cell. 2004; 6(4): 463-477. doi: 10.1016/S1534-5807(04)00099-1

13. Kim KH, Lee MS. Autophagy- a key player in cellular and body metabolism. Nat Rev Endocrinol. 2014; 10(6): 322-337.
doi: 10.1038/nrendo.2014.35

14. Zaibi MS, Stocker CJ, O’Dowd J, et al. Roles of GRP41 and GRP43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 2010; 584: 2381-2386. doi: 10.1016/j.febslet.2010.04.027

15. Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011; 13(5): 495-504. doi: 10.1016/j.cmet.2011.04.004

16. Filimonenko M, Stuffers S, Raiborg C, et al. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol. 2007; 179(3): 485-500. doi: 10.1083/jcb.200702115

17. Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB. ESCRTIII dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol. 2007; 17: 1561-1567. doi: 10.1016/j. cub.2007.07.029

18. Matsunaga K, Saitoh T, Tabata K, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol. 2009; 11(4): 385-396. doi: 10.1038/ncb1846

19. Zhong Y, Wang QJ, Li X, et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1- hosphatidylinositol-3-kinase complex. Nat Cell Biol. 2009; 11(4): 468-476. doi: 10.1038/ncb1854

20. Center for Disease Control and Prevention. Obesity and overweight. Website: http://www.cdc.gov/nchs/fastats/obesityoverweight.htm. 2012; Accessed 2014.

21. Kovsan J, Bluher M, Tarnovscki T, et al. Altered Autophagy in Human Adipose Tissue in Obesity. JCEM. 2011; 96: 268-277.
doi: 10.1210/jc.2010-1681

22. Christian P, Sacco J, Adeli K. Autophagy: Emerging roles in lipid homeostasis and metabolic control. Biochim Biophys Acta. 2013; 1831(4): 819-824. doi: 10.1016/j.bbalip.2012.12.009

23. Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature. 2009; 458(7242): 1131-1135.
doi: 10.1038/nature07976

24. Singh R, Xiang Y, Wang Y, et al. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest. 2009; 119(11): 3329-3339.
doi: 10.1172/JCI39228

25. Baerga R, Zhang Y, Chen PH, Goldman S, Jin S. Targeted deletion of autophagy-related (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy. 2009; 5(8): 1118-1130. doi: 10.4161/auto.5.8.9991

26. Fujimoto T, Ohsak Y. The Proteasomal and Autophagic Pathways Converge on Lipid Droplets. Autophagy. 2006; 2(4): 299-301.
doi: 10.4161/auto.2904

27. Ohsaki Y, Cheng J, Fujita A, Tokumoto T, Fujimoto T. Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B. Mol Biol Cell. 2006; 17(6): 2674-2683. doi: 10.1091/mbc.E05-07-0659

28. Pan M, Maitin V, Parathath S, et al. Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control. PNAS. 2008; 105(15):5862-5867. doi: 10.1073/pnas.0707460104

29. Martyn JA, Kaneki M, Yasuhara S. Obesity-Induced Insulin Resistance and Hyperglycemia: Etiological Factors and Molecular Mechanisms. Anesthesiology. 2008; 109(1): 137-148. doi: 10.1097/ALN.0b013e3181799d45

30. Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Nutrition. 2006; 22(7-8): 830-844. doi: 10.1016/j.nut.2006.04.008

31. Yang Z, Klionsky DJ. Mammalian autophagy: Core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010; 22(2): 124-131.
doi: 10.1016/j.ceb.2009.11.014

32. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6): 900- 917.
doi: 10.1016/j.cell.2010.02.034

33. Liu HY, Han J, Cao SY, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: Inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 2009; 284: 31484-31492. doi: 10.1074/jbc.M109.033936

34. Öst A, Svensson K, Ruishalme I, et al. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med. 2010; 16(7-8): 235-246. doi: 10.2119/molmed.2010.00023

35. Deblon N, Bourgoin L, Veyrat-Durebex C, et al. Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats. Br J Pharmacol. 2012; 165(7):2325-2340. doi: 10.1111/j.1476-5381.2011.01716.x

36. Goodridge AG, Ball EG. Lipogenesis in the pigeon: In vivo studies. Am J Physiol. 1967; 213(1): 245-249.
doi: 10.1152/ajplegacy.1967.213.1.245

37. Leveille GA, O’Hea EK, Chakbabarty K. In vivo lipogenesis in the domestic chicken. Proc Soc Exp Biol Med. 1968; 128(2): 398-401 .
doi: 10.3181/00379727-128-33022

38. Leveille GA, Romsos DR, Yeh YY, O’Hea EK. Lipid Biosynthesis in the Chick. A consideration of site of synthesis, influence of diet and possible regulatory mechanisms. Poult Sci.1975; 54: 1075-1093. doi: 10.3382/ps.0541075

39. Trayhurn P, Wusteman MC. Lipogenesis in genetically diabetic (db/db) mice: developmental changes in brown adipose tis-sue, white adipose tissue and the liver. Biochim Biophys Acta.1990; 1047: 168-174. doi: 10.1016/0005-2760(90)90043-W

40. Krzysik-Walker SM, Oco´n-Grove OM, Maddineni SR, Hendricks III GL, Ramachandran R. Is visfatin an adipokine or myokine? evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinol. 2008; 149(4): 1543-1550. doi: 10.1210/en.2007-1301

41. Scheuermann GN, Bilgili SF, Hess JB, Mulvaney DR. Breast Muscle Development In Commercial Broiler Chickens. Poult Sci. 2003; 82: 1648-1658. doi: 10.1093/ps/82.10.1648

42. Hood R. The Cellular Basis for Growth of the Abdominal Fat Pad in Broiler-Type Chickens. Poult Sci. 1982; 61(1): 117-121.
doi: 10.3382/ps.0610117

43. Dupont J, Dagou C, Derouet M, Simon J, Taouis M. Early steps of insulin receptor signaling in chicken and rat: apparent refractoriness in chicken muscle. Dom Animal Endocrinol. 2003; 26(2): 127-142. doi: 10.1016/j.domaniend.2003.09.004

44. Simon J, Freychet P, Rosselin G. A study of insulin binding sites in the chicken tissues. Diabetologia. 1977; 13(3): 219-228.
doi: 10.1007/bf01219703

45. Seki Y, Sato K, Kono T, Abe H, Akiba Y. Broiler Chickens (Ross Strain) lack inculin-responsive glucose transporter GLUT4 and have GLUT8 cDNA. Gen Comp Endocrinol. 2003;133: 80-87. doi: 10.1016/S0016-6480(03)00145-X

46. Akiba Y, Chida Y, Takahashi T, Ohtomo Y, Sato K, Takahashi K. Persistent hypoglycemia induced by continuous insulin infusion in broiler chickens. Br Poult Sci. 1999; 40 :701-705. doi: 10.1080/00071669987124

47. Piekarski A, Khaldi S, Greene E, et al. Tissue distribution, gender- and genotype-dependent expression of autophagy-related genes in avian species. PLOS One. 2014; 9(11): e112449. doi: 10.1371/journal.pone.0112449

48. Kaushik S, Rodriguez-Navarro JA, Arias E. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance.  Cell Metab. 2011; 14(2): 173-183. doi: 10.1016/j.cmet.2011.06.008

49. Satterlee DG, Johnson WA. Selection of Japanese quail for contrasting blood corticosterone response to immobilization. Poult Sci. 1988; 67(1): 25-32. doi: 10.3382/ps.0670025

LATEST ARTICLES

Chest X-ray Showed a Hazy Left Upper Lung Infiltrate

A Noteworthy Case of Myasthenic Crisis Induced by Levofloxacin

Ada Young*, Ramya Ramesh and Milind Awale

doi.

The Right Thigh Anterior Compartment was Swollen, and the Skin was Ulcerated due to the Traditional Cautery

Primary Skeletal Muscle Lymphoma: A Case Report and Literature Review

Solomon Bishaw*, Addisu Alemu and Abel Tefera

doi.

An Unusual Presentation of Encephalitis in a Patient with Lyme Neuroborreliosis

Maithily Patel*, Jazmin Jatana, Ramya Ramesh and Milind Awale

doi.

Practical Pointers for Drug Development and Medical Affairs

Gerald L. Klein*, Roger E. Morgan, Shabnam Vaezzadeh, Burak Pakkal and Pavle Vukojevic

doi.

10.17140/CTPOJ-7-125

Prevalence and Risk Factors of Subclinical Mastitis of Goats in Banadir Region, Somalia

Omar M. Salah*, Yasin H. Sh-Hassan, Moktar O. S. Mohamed, Mohamed A. Yusuf and Abas S. A. Jimale

doi.10.17140/VMOJ-9-184

LATEST ARTICLES